Louis O'Dea

All filings by Louis O'Dea on record concern Akcea Therapeutics, Inc. Between 19 September 2019 and 23 March 2020, the trades on record add up to 4 filings.

No open-market purchase appears, only 1 sale worth €35k. Other entries cover 3 share grants. So far in 2020, the count stands at no purchases and 1 sale.

The latest filing, published on 25 March 2020, reports an open-market sale of €35k in Akcea Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.